Phibro Animal Health (NASDAQ:PAHC) Trading Down 6.5%

Shares of Phibro Animal Health Co. (NASDAQ:PAHC) were down 6.5% on Wednesday . The company traded as low as $12.73 and last traded at $12.73. Approximately 55,607 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 140,861 shares. The stock had previously closed at $13.61.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Tuesday, April 9th.

Phibro Animal Health Price Performance

The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.60 and a current ratio of 3.12. The stock has a 50 day moving average of $12.83 and a two-hundred day moving average of $11.77. The firm has a market capitalization of $515.57 million, a P/E ratio of 35.36, a P/E/G ratio of 4.63 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.27 by $0.06. The company had revenue of $249.90 million for the quarter, compared to the consensus estimate of $242.91 million. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. Sell-side analysts predict that Phibro Animal Health Co. will post 1.12 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 6th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 3.77%. The ex-dividend date was Tuesday, March 5th. Phibro Animal Health’s dividend payout ratio is currently 133.33%.

Institutional Trading of Phibro Animal Health

Institutional investors and hedge funds have recently modified their holdings of the company. Barclays PLC increased its position in shares of Phibro Animal Health by 59.8% during the third quarter. Barclays PLC now owns 35,638 shares of the company’s stock valued at $456,000 after purchasing an additional 13,332 shares during the period. Trexquant Investment LP increased its position in shares of Phibro Animal Health by 143.6% during the third quarter. Trexquant Investment LP now owns 35,872 shares of the company’s stock valued at $458,000 after purchasing an additional 21,147 shares during the period. Brandes Investment Partners LP increased its position in shares of Phibro Animal Health by 38.5% during the third quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company’s stock valued at $23,922,000 after purchasing an additional 520,697 shares during the period. China Universal Asset Management Co. Ltd. increased its position in shares of Phibro Animal Health by 358.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock valued at $27,000 after purchasing an additional 1,843 shares during the period. Finally, New York State Common Retirement Fund increased its position in shares of Phibro Animal Health by 20.9% during the third quarter. New York State Common Retirement Fund now owns 69,944 shares of the company’s stock valued at $893,000 after purchasing an additional 12,110 shares during the period. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.